Effect of cAMP elevation on the NPY gene transcription.
Pance
A
A
Physiological Laboratory, University of Cambridge.
Balbi
D
D
Holliday
N
N
Allen
J M
JM
D000262:Adenylyl Cyclases / Q000378:metabolism; D000310:Adrenal Gland Neoplasms; D000818:Animals; D015500:Chloramphenicol O-Acetyltransferase / Q000096:biosynthesis; D005576:Colforsin / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors; D004789:Enzyme Activation; D015870:Gene Expression / Q000187:drug effects*; D007546:Isoquinolines / Q000494:pharmacology; D007700:Kinetics; D009281:Naphthalenes; D009478:Neuropeptide Y / Q000096:biosynthesis*; D016716:PC12 Cells; D010673:Pheochromocytoma; D011083:Polycyclic Compounds / Q000494:pharmacology; D011401:Promoter Regions, Genetic; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D051381:Rats; D013449:Sulfonamides; D014158:Transcription, Genetic / Q000187:drug effects*
D007546:Isoquinolines; D009281:Naphthalenes; D009478:Neuropeptide Y; D011083:Polycyclic Compounds; D013449:Sulfonamides; D005576:Colforsin; D000242:Cyclic AMP; D015500:Chloramphenicol O-Acetyltransferase; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D000262:Adenylyl Cyclases; C058819:calphostin C; C063509:N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide